Yecla, Arman D.
HRN: 22-35-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/04/2023
01/10/2023
IV
600mg
Q6
Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes